首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry
【24h】

Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry

机译:沉淀和超高压液相色谱-串联质谱法定量测定人血清中的抗抑郁药和抗精神病药

获取原文
获取原文并翻译 | 示例
           

摘要

The present article describes the quantification of mirtazapine, O-desmethylvenlafaxine, quetiapine, venlafaxine, and ziprasidone (group 1), and amitriptyline, citalopram, clomipramine, clozapine, desmethylclomipramine, desipramine, imipramine, and nortriptyline (group 2) in human serum for therapeutic drug monitoring. The method was developed to replace old techniques which applied solid phase extraction and ultra-violet detection. The old methods had reached their limit of capacity regarding the number of samples and co-medicated drugs interfering with the detection. Serum samples were precipitated with zinc sulphate and methanol containing a stable isotope labelled analog for each analyte. Quantitative analysis was performed by ultra high pressure liquid chromatography combined with a tandem mass spectrometer using a Zorbax SB-C8 column (2.0 × 50 mm; 1.8 μm) with a mobile phase consisting of 0.1% formic acid in water and methanol, respectively. The total run time of the chromatography was 4. min. Precision and trueness varied from 2.6% to 14.9% and 87.6% to 103.5%, respectively. At the lower limit of quantification, precision was up to 17.9% and trueness varied from 89.5% to 111.5%. A five point standard curve covering the clinically relevant ranges with a power function fit was applied for calibration. Ion suppression from matrix effects and internal standards were thoroughly investigated and are discussed. Process efficiency rates varied from 42% to 99%. The method has shortened the response time, reduced interference from other drugs, avoided acetonitrile usage, and reduced the amount of serum needed for analysis 50-fold.
机译:本文描述了人血清中米氮平,O-去甲基文拉法辛,喹硫平,文拉法辛和齐拉西酮(第1组)以及阿米替林,西酞普兰,氯米帕明,氯氮平,去甲基氯米帕明,地昔帕明,丙米拉明和去甲替林(第2组)的定量药物监测。开发该方法以替代应用固相萃取和紫外检测的旧技术。关于干扰检测的样品和联合药物数量,旧方法已达到其能力极限。用硫酸锌和甲醇沉淀血清样品,其中每种化合物均含有稳定的同位素标记的类似物。使用Zorbax SB-C8色谱柱(2.0×50 mm; 1.8μm),通过超高压液相色谱结合串联质谱仪进行定量分析,流动相分别由0.1%甲酸的水溶液和甲醇组成。色谱的总运行时间为4分钟。准确性和真实性分别从2.6%到14.9%和87.6%到103.5%不等。在定量的下限,精度高达17.9%,真实度从89.5%到111.5%。使用覆盖了临床相关范围且具有幂函数拟合的五点标准曲线进行校准。彻底研究了基质效应和内标对离子的抑制作用并进行了讨论。工艺效率从42%到99%不等。该方法缩短了响应时间,减少了对其他药物的干扰,避免了使用乙腈,并将分析所需的血清量减少了50倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号